Versameb AG
Versameb AG is a privately held biotechnology company focusing on discovering and developing innovative RNA-based drugs for modulation of protein expression, including the ability to simultaneously in...
Versameb AG's Basic Information
Headquarters
Basel, Basel-City, Switzerland
Website
Founded Year
2017
Headcount
11 - 50
Specialties
RNAmRNAVERSagileRNA TherapeuticsSUISolid TumorsStress Urinary Incontinence
Versameb AG's Competitors
Wyeth Ayerst Laboratories
Wayne, Pennsylvania, United States
Bioleap, Inc.
Tampa, Florida, United States
BrevisRefero Corporation
Toronto, Ontario, Canada
Redox Diagnostics LLC
UD technologies
Vadodara, Gujarat, India
Employee Insights
Employee Function
Employee Location
Versameb AG's Top Employees
Paul Korner, M.D., M.B.A.
Board Member
Reinhard Ambros
Chairman Of The Board
Claudia Bohnert
Principal Research Associate
Sina Zimmerli
Research Associate
Isabel Ferreira
Chief Business Officer
Find Your Next Customer with Better Data
Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.
⭐Top-ranked on G2 Crowd
🛡️GDPR compliant•Cancel anytime
✨Free credits every month!
Frequently Asked Questions Regarding Versameb AG
Where is Versameb AG's headquarter located?
Versameb AG's headquarter are located at Switzerland.
How many employees does Versameb AG have?
Versameb AG has 11 - 50 employees.
What is Versameb AG's official website?
Versameb AG's official website is https://www.versameb.com
What does Versameb AG do?
Versameb AG is a privately held biotechnology company focusing on discovering and developing innovative RNA-based drugs for modulation of protein expression, including the ability to simultaneously in...
What specialty does Versameb AG have?
RNAmRNAVERSagileRNA TherapeuticsSUISolid TumorsStress Urinary Incontinence
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
